Courtney Marabella
Articles
Patients With HER2+ Breast Cancer and Brain Metastases Achieve Better OS With Tucatinib Triplet Regimen
January 09, 2022
Article
A triplet regimen of tucatinib, trastuzumab, and capecitabine helped patients with HER2-positive metastatic breast cancer and brain metastases live longer with reduced disease progression compared with trastuzumab and capecitabine alone.
Adjuvant mFOLFOX6 Increases Hepatectomy Efficacy, Improves DFS in Liver-Only Metastatic CRC
January 07, 2022
Article
Disease-free survival in liver-only metastatic CRC was significantly improved by introducing adjuvant mFOLFOX6 chemotherapy to hepatectomy
Adding Bevacizumab to Pembrolizumab Enhances Response Rates in Epithelial Ovarian Cancer
December 02, 2021
Article
The addition of bevacizumab was found to boost responses in patients with epithelial ovarian cancer receiving pembrolizumab.
NBTXR3 Plus Radiotherapy Does Not Negatively Affect Quality of Life in Soft Tissue Sarcoma
December 01, 2021
Article
An expert from the Institut Curie discusses the risk-benefit ratio associated with NBTXR3 plus radiotherapy for the treatment of patients with soft tissue sarcoma.
COVID-19 Vaccines May Be Less Effective in Patients with Lymphoid Malignancies
November 24, 2021
Article
Physicians urge patients with lymphoid malignancies to continue precautionary COVID-19 measures regardless of vaccination status.
Oncologists Attribute Pandemic-Related Burnout to Loss of In-Person Patient Interactions
November 23, 2021
Article
Data presented at the 2021 ASCO Quality Care Symposium demonstrated that in-person interactions had a bigger impact of professional satisfaction than financial stability.
Patients with NETs Can Stop Perioperative Octreotide without Inducing Carcinoid Crisis
November 17, 2021
Article
New research found that the discontinuation of prophylactic octreotide was not associated with an increased rate or duration of carcinoid crisis in patients with neuroendocrine tumors.
More Research Needed to Determine Biologic Prognostic Factors in Myoepithelial Tumors
November 07, 2021
Article
More research on the various clinical, pathological, and outcome differences in myoepithelial tumors is needed to offer better prognoses for patients with varying tumor characteristics.
Pediatric Patients With Cancer Experience More Severe Illness After Contracting COVID-19
October 27, 2021
Article
A greater percentage of children with cancer experienced severe illness and mortality after becoming infected with COVID-19 compared with children in the general pediatric population.
UGN-102 Induces Durable Responses in Patients with Low-Grade Intermediate-Risk NMIBC
October 24, 2021
Article
Approximately 73% of patients with NMIBC who experienced a complete response after non-surgical primary chemoablation using mitomycin-containing reverse thermal gel UGN-102 remained disease free at 9 months.